22
Participants
Start Date
December 14, 2021
Primary Completion Date
August 15, 2022
Study Completion Date
August 15, 2022
blood collection for research (next generation sequencing [NGS])
participants will have whole blood collected for NGS
blood collection for research (HLA typing)
participants will have whole blood collected for HLA typing
blood collection for research (circulating tumor DNA [ctDNA])
participants will have whole blood collected for ctDNA detection
Virginia Cancer Specialists, Fairfax
Miami Cancer Institute, Miami
Advanced Research, Tamarac
Sarah Cannon, Nashville
The Christ Hospital, Cincinnati
Astera Cancer Care, East Brunswick
Lead Sponsor
Gritstone bio, Inc.
INDUSTRY